A Study of Pazopanib Safety and Efficacy in Patients With Advanced Clear Cell Renal Cell Carcinoma and ECOG Performance Status 2 (Pazo2): An Open label, Multicentre, Single Arm, Phase II Trial

Autor: Zarkar, Anjali, Pirrie, Sarah, Stubbs, Clive, Hodgkins, Anne-Marie, Farrugia, David, Fife, Kathryn, MacDonald-Smith, Carey, Vasudev, Naveen, Porfiri, Emilio
Zdroj: In Clinical Genitourinary Cancer October 2022 20(5):473-481
Databáze: ScienceDirect
Externí odkaz: